Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
408.04
+2.77 (0.68%)
Dec 24, 2024, 12:26 PM EST - Market open

Vertex Pharmaceuticals Stock Forecast

Stock Price Forecast

The 25 analysts with 12-month price forecasts for VRTX stock have an average target of 507.72, with a low estimate of 408 and a high estimate of 586. The average target predicts an increase of 24.43% from the current stock price of 408.04.

Analyst Consensus: Buy
Target Low Average Median High
Price $408 $507.72 $520 $586
Change -0.01% +24.43% +27.44% +43.61%

Analyst Ratings

The average analyst rating for VRTX stock from 30 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '24Aug '24Sep '24Oct '24Nov '24Dec '24
Strong Buy 899101112
Buy 1099888
Hold 677999
Sell 000000
Strong Sell 111111
Total 252626282930

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Truist Securities
Truist Securities
Strong Buy
Maintains
$550$460
Strong Buy Maintains $550$460 +12.73% Dec 23, 2024
Scotiabank
Scotiabank
Hold
Maintains
$426$430
Hold Maintains $426$430 +5.38% Dec 23, 2024
JP Morgan
JP Morgan
Buy
Maintains
$503$500
Buy Maintains $503$500 +22.54% Dec 23, 2024
Barclays
Barclays
Hold
Maintains
$509$418
Hold Maintains $509$418 +2.44% Dec 20, 2024
BMO Capital
BMO Capital
Buy
Maintains
$566$520
Buy Maintains $566$520 +27.44% Dec 20, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
11.11B
from 9.87B
Increased by 12.54%
Revenue Next Year
12.05B
from 11.11B
Increased by 8.52%
EPS This Year
0.60
from 13.89
Decreased by -95.71%
EPS Next Year
19.19
from 0.60
Increased by 3,121.81%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
4.16B6.21B7.57B8.93B9.87B11.11B12.05B13.24B
Revenue Growth
36.59%49.08%22.06%17.91%10.51%12.54%8.52%9.85%
EPS
4.5110.299.0112.8213.890.6019.1920.84
EPS Growth
-44.24%128.16%-12.44%42.29%8.35%-95.71%3,121.81%8.61%
Forward PE
-----685.0021.2619.58
No. Analysts -----393929
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 11.5B 14.4B 16.3B
Avg 11.1B 12.1B 13.2B
Low 10.6B 11.0B 11.6B

Revenue Growth

Revenue Growth 202420252026202720282029
High
16.8%
29.8%
35.2%
Avg
12.5%
8.5%
9.8%
Low
7.3%
-0.5%
-3.4%

EPS Forecast

EPS 202420252026202720282029
High 2.13 23.10 28.03
Avg 0.60 19.19 20.84
Low 0.05 15.95 16.73

EPS Growth

EPS Growth 202420252026202720282029
High
-84.7%
3,777.9%
46.1%
Avg
-95.7%
3,121.8%
8.6%
Low
-99.6%
2,578.4%
-12.8%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.